- Preview Available
- Scholarly Journal
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 10607.
DOI:10.1038/s41598-025-94373-8
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.